BI-RADS (Breast Imaging-Reporting and Data System) is a risk assessment and quality assurance tool developed by American College of Radiology that provides a widely accepted lexicon and reporting schema for imaging of the...
乳腺BI-RADS,即美国放射学会(ACR)制定并推荐的乳腺影像报告与数据系统(breast imaging reporting and data system),是乳腺影像学检查分类评估的标准。 乳腺BI-RADS分类的目的和意义 使诊断报告规范化,使用统一的专业术语和标准的诊断归类及检查程序,以便于不同...
[2] 曾玲, 曹炎, 罗鹏,等. 乳腺BI-RADS 3类病变的超声随访结果[J]. 分子影像学杂志, 2018, 41(4):51-54. [3]Chae E Y , Cha J H , Shin H J , et al. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound[J]. Ajr American Journal ...
BI-RADS 3Young womenFollow-upBenign breast lesionObjective: To evaluate the outcome of repeated short-term follow-up with ultrasound in no high-risk young patients with a BI-RADS3 lesion at first examination.Marcon, MagdaFrauenfelder, ThomasBecker, Anton S.Dedes, Konstantin J.Boss, Andreas...
作为一种质控手段,美国放射学会提出的 BI-RADS 分类不仅被应用于指导乳腺 X 线诊断,也被扩展应用于乳腺超声和 MRI 诊断,由于使用了统一的专业术语、标准的诊断归类及检查程序,其应用有利于超声医师与临床医师之间的交流。 其中, BI-RADS 3 类乳腺病灶为良性的可能性大,恶性比例小于 2%。然而,若能早期筛查出这类...
1.XXX that do not match all ultrasound features (1-3 non-XXX. 2.Solid masses with benign ultrasound features in patients over 40 years old may not have XXX due to the high incidence of malignancy (4A). Category 4 XXX: 4A: XXX XXX report is usually non-malignant。and follow-up or XX...
彩超birads分级标准彩超 英文回答: BIRADS (Breast Imaging Reporting and Data System) is a standardized classification system used in breast ultrasound to assess the likelihood of malignancy or the need for further evaluation. It was developed by the American College of Radiology (ACR) to provide ...
目的:分析乳腺超声随访生长型乳腺影像报告和数据系统(BI-RADS)类病变与恶性肿瘤相关的特征。方法:选择2018年11月~2021年11月医院随访115例生长型BI-RADS3类病变患者作为研究对象,患者诊断与随访均行乳腺超声检查,分析患者随访期间生长型BI-RADS3类病变变化,生长型BI-RADS3类病变变化与超声检查表现相关性,生长型BI-RA...
目的 探讨超声造影(contrast-enhancement ultrasound,CEUS)检查对提高乳腺BI-RADS 3、4类肿块良恶性诊断的价值。方法 收集2019年3月至2020年4月在辽宁省朝阳市中心医院就诊患者71例,最终经穿刺活检或手术病理证实的乳腺肿块共76个。对纳入研究的肿块行常规超声及CEUS检查,并行BI-RADS分类及CEUS评分。根据CEUS评分结果,...
一般认为,BI-RADS 3类的影像最终诊断为恶性的可能性≤2%.然而,在临床实践中BI-RADS的判断受到众多因素的影响,以至于BI-RADS 3类的肿瘤病理确诊恶性的几率可能超过2%.研究目的使用Meta分析的方法系统评价BIRADS-3对乳腺癌诊断的临床意义,为是否应该改变BI-RADS 3类结节恶性可能性≤2%的结论提供佐证.研究方法系统检索...